AU2003241904A1 - Novel method of screening - Google Patents

Novel method of screening

Info

Publication number
AU2003241904A1
AU2003241904A1 AU2003241904A AU2003241904A AU2003241904A1 AU 2003241904 A1 AU2003241904 A1 AU 2003241904A1 AU 2003241904 A AU2003241904 A AU 2003241904A AU 2003241904 A AU2003241904 A AU 2003241904A AU 2003241904 A1 AU2003241904 A1 AU 2003241904A1
Authority
AU
Australia
Prior art keywords
screening
novel method
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003241904A
Inventor
Shuji Hinuma
Masaki Hosoya
Yasuaki Ito
Hideki Kizawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2003241904A1 publication Critical patent/AU2003241904A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003241904A 2002-05-31 2003-05-29 Novel method of screening Abandoned AU2003241904A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-159403 2002-05-31
JP2002159403 2002-05-31
PCT/JP2003/006755 WO2003105885A1 (en) 2002-05-31 2003-05-29 Novel method of screening

Publications (1)

Publication Number Publication Date
AU2003241904A1 true AU2003241904A1 (en) 2003-12-31

Family

ID=29727528

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003241904A Abandoned AU2003241904A1 (en) 2002-05-31 2003-05-29 Novel method of screening

Country Status (2)

Country Link
AU (1) AU2003241904A1 (en)
WO (1) WO2003105885A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01233219A (en) * 1988-03-12 1989-09-19 Nippon Oil & Fats Co Ltd Carcinostatic agent composition
EP1025223A2 (en) * 1997-09-19 2000-08-09 Magainin Pharmaceuticals Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
US6180365B1 (en) * 1998-11-06 2001-01-30 Smithkline Beecham Corporation Polynucleotide encoding a Mouse 7-transmembrane GPR43 receptor

Also Published As

Publication number Publication date
WO2003105885A1 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
AU2003277596A1 (en) Method of deuterization
AU2003269126A1 (en) Method of combining materials
AU2003277663A1 (en) Screening method
AU2002249467A1 (en) Screening method
AUPS096002A0 (en) Method of construction
AU2003242340A1 (en) Novel screening method
AU2003227268A1 (en) Novel screening method
AU2003292680A1 (en) Method of selecting novel immunosuppressant
AUPS337802A0 (en) Method of screening for antidiabetic agents
AU2003254579A1 (en) Methods of screening for schizophrenia
AU2003285503A1 (en) Screening method
AU2003202622A1 (en) A method of screening
AU2003242342A1 (en) Novel screening method
AU2003235231A1 (en) Method of synthesizing cf3-chf-cf2-nr2
AU2003241904A1 (en) Novel method of screening
AU2003217008A1 (en) Screening method
AU2003276825A1 (en) Method of immunotherapy
AU2002354247A1 (en) Screening method
AU2003235310A1 (en) Novel screening method
AU2003248955A1 (en) Screening method
AU2003222584A1 (en) Method of producing organoacyloxysilanes
AU2003290512A1 (en) Method of weldbonding
AU2003299623A1 (en) Method of making mercaptoalkylalkyldialkoxysilanes
AU2002355031A1 (en) Method of synthesizing macrosphelides
AUPS286102A0 (en) Screening method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase